Cullins in Human Intra-Uterine Growth Restriction: Expressional and Epigenetic Alterations

Placenta

Volumn 31, Issue 2, 2010, Pages 151-157

  Gascoin Lachambre, G ^a,b   Buffat, C ^c   Rebourcet, R ^a   Chelbi, S T ^a   Rigourd, V ^a   Mondon, F ^a   Mignot, T M ^a   Legras, E ^c   Simeoni, U ^c   Vaiman, D ^a   Barbaux, S ^a  

^a INSTITUT COCHIN   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Cullin; IUGR; Placenta; Preeclampsia; Proteasome

Indexed keywords

COMPLEMENTARY DNA; CULLIN; CULLIN 4B; CULLIN 7; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CUL7 GENE; EPIGENETICS; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; METHYLATION; NONHUMAN; PLACENTA; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; UPREGULATION;

EID: 75049083513     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.11.008     Document Type: Article

References (42)

1. ACOG. Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 72 1 (2001) 85-96
2. Mandruzzato G., Antsaklis A., Botet F., Chervenak F.A., Figueras F., Grunebaum A., et al. Intrauterine restriction (IUGR). J Perinat Med 36 4 (2008) 277-281
3. Froen J.F., Gardosi J.O., Thurmann A., Francis A., and Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 83 9 (2004) 801-807
4. Richardus J.H., Graafmans W.C., Verloove-Vanhorick S.P., and Mackenbach J.P. Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit. BJOG 110 2 (2003) 97-105
5. Gardosi J., Mul T., Mongelli M., and Fagan D. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 105 5 (1998) 524-530
6. Garite T.J., Clark R., and Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 191 2 (2004) 481-487
7. Phipps K., Barker D.J., Hales C.N., Fall C.H., Osmond C., and Clark P.M. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36 3 (1993) 225-228
8. Ravelli A.C., van der Meulen J.H., Michels R.P., Osmond C., Barker D.J., Hales C.N., et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351 9097 (1998) 173-177
9. Barker D.J., Winter P.D., Osmond C., Margetts B., and Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 2 8663 (1989) 577-580
10. Ergaz Z., Avgil M., and Ornoy A. Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models?. Reprod Toxicol 20 3 (2005) 301-322
11. McMillen I.C., and Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85 2 (2005) 571-633
12. McArdle H.J., Andersen H.S., Jones H., and Gambling L. Fetal programming: causes and consequences as revealed by studies of dietary manipulation in rats - a review. Placenta 27 Suppl. A (2006) S56-S60
13. Vaiman D., Mondon F., Garces-Duran A., Mignot T.M., Robert B., Rebourcet R., et al. Hypoxia-activated genes from early placenta are elevated in Preeclampsia, but not in Intra-Uterine Growth Retardation. BMC Genomics 6 (2005) 111
14. Buffat C., Mondon F., Rigourd V., Boubred F., Bessieres B., Fayol L., et al. A hierarchical analysis of transcriptome alterations in intrauterine growth restriction (IUGR) reveals common pathophysiological pathways in mammals. J Pathol 213 3 (2007) 337-346
15. Rigourd V., Chauvet C., Chelbi S.T., Rebourcet R., Mondon F., Letourneur F., et al. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS ONE 3 12 (2008) e3905
16. Huber C., Dias-Santagata D., Glaser A., O'Sullivan J., Brauner R., Wu K., et al. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet 37 10 (2005) 1119-1124
17. Kapoor A., Dunn E.A., Kostaki A., Andrews M.H., and Matthews S.G. Fetal programming of hypothalamo-pituitary-adrenal (hpa) function: prenatal stress and glucocorticoids. J Physiol (2006)
18. Xu X., Sarikas A., Dias-Santagata D.C., Dolios G., Lafontant P.J., Tsai S.C., et al. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 30 4 (2008) 403-414
19. Jiang Y.H., Bressler J., and Beaudet A.L. Epigenetics and human disease. Annu Rev Genomics Hum Genet 5 (2004) 479-510
20. Pickart C.M. Back to the future with ubiquitin. Cell 116 2 (2004) 181-190
21. Petroski M.D., and Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6 1 (2005) 9-20
22. Dealy M.J., Nguyen K.V., Lo J., Gstaiger M., Krek W., Elson D., et al. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet 23 2 (1999) 245-248
23. Singer J.D., Gurian-West M., Clurman B., and Roberts J.M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 13 18 (1999) 2375-2387
24. Li B., Ruiz J.C., and Chun K.T. CUL-4A is critical for early embryonic development. Mol Cell Biol 22 14 (2002) 4997-5005
25. Zou Y., Liu Q., Chen B., Zhang X., Guo C., Zhou H., et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am J Hum Genet 80 3 (2007) 561-566
26. Ohtake F., Baba A., Takada I., Okada M., Iwasaki K., Miki H., et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446 7135 (2007) 562-566
27. Bazot M., Detchev R., Cortez A., Amouyal P., Uzan S., and Darai E. Transvaginal sonography and rectal endoscopic sonography for the assessment of pelvic endometriosis: a preliminary comparison. Hum Reprod 18 8 (2003) 1686-1692
28. Tsunematsu R., Nishiyama M., Kotoshiba S., Saiga T., Kamura T., and Nakayama K.I. Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development. Mol Cell Biol 26 16 (2006) 6157-6169
29. Lubchenco L.O., Hansman C., Dressler M., and Boyd E. Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 32 (1963) 793-800
30. Mondon F., Mignot T.M., Rebourcet R., Jammes H., Danan J.L., Ferre F., et al. Profiling of oxygen-modulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products. Physiol Genomics 22 1 (2005) 99-107
31. Meller M., Vadachkoria S., Luthy D.A., and Williams M.A. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26 8-9 (2005) 601-607
32. Dupont J.M., Tost J., Jammes H., and Gut I.G. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 333 1 (2004) 119-127
33. Tost J., El Abdalaoui H., and Gut I.G. Serial pyrosequencing for quantitative DNA methylation analysis. Biotechniques 40 6 (2006) 721-722 724, 726
34. Sarikas A., Xu X., Field L.J., and Pan Z.Q. The cullin7 E3 ubiquitin ligase: a novel player in growth control. Cell Cycle 7 20 (2008) 3154-3161
35. Mieulet V., and Lamb R.F. Shooting the messenger: CULLIN' insulin signaling with Fbw8. Dev Cell 14 6 (2008) 816-817
36. Chiang M.H., Chen L.F., and Chen H. Ubiquitin-conjugating enzyme UBE2D2 is responsible for FBXW2 (F-box and WD repeat domain containing 2)-mediated human GCM1 (glial cell missing homolog 1) ubiquitination and degradation. Biol Reprod 79 5 (2008) 914-920
37. Chiang M.H., Liang F.Y., Chen C.P., Chang C.W., Cheong M.L., Wang L.J., et al. Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia. J Biol Chem 284 26 (2009) 17411-17419
38. Chakraborty C., Gleeson L.M., McKinnon T., and Lala P.K. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 80 2 (2002) 116-124
39. Chelbi S.T., Mondon F., Jammes H., Buffat C., Mignot T.M., Tost J., et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 49 1 (2007) 76-83
40. Chim S.S., Tong Y.K., Chiu R.W., Lau T.K., Leung T.N., Chan L.Y., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 102 41 (2005) 14753-14758
41. Murrell A., Heeson S., and Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 36 8 (2004) 889-893
42. Tsutsumi T., Kuwabara H., Arai T., Xiao Y., and Decaprio J.A. Disruption of the Fbxw8 gene results in pre- and postnatal growth retardation in mice. Mol Cell Biol 28 2 (2008) 743-751